ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of …
Committee Members, G Gregoratos, J Abrams… - Circulation, 2002 - Am Heart Assoc
(1) Changes in recommendations and levels of evidence were made either because of new
randomized trials or because of the accumulation of new clinical evidence and the …
randomized trials or because of the accumulation of new clinical evidence and the …
The proarrhythmic potential of implantable cardioverter-defibrillators
SL Pinski, GJ Fahy - Circulation, 1995 - Am Heart Assoc
The implantable cardioverter-defibrillator (ICD) is remarkably effective in preventing sudden
cardiac death in high-risk patients, but it also has the capacity to provoke or worsen cardiac …
cardiac death in high-risk patients, but it also has the capacity to provoke or worsen cardiac …
Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation
LB Mitchell, EA Pineda, JL Titus, PM Bartosch… - Journal of the American …, 2002 - jacc.org
Objectives: The purpose of this study was to determine the mechanisms of sudden death
(SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular …
(SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular …
Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems
DP Zipes, D Roberts - Circulation, 1995 - Am Heart Assoc
Background The purpose of the present report was to document clinical experience derived
from the implantation of 2834 epicardial and endocardial cardioverter-defibrillators (ICDs) in …
from the implantation of 2834 epicardial and endocardial cardioverter-defibrillators (ICDs) in …
High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator
T Korte, H Köditz, M Niehaus, T Paul… - Pacing and clinical …, 2004 - Wiley Online Library
Appropriate and inappropriate therapies of implantable cardioverter defibrillators have a
major impact on morbidity and quality of life in ICD recipients, but have not been …
major impact on morbidity and quality of life in ICD recipients, but have not been …
Implantable transvenous cardioverter-defibrillators.
GH Bardy, B Hofer, G Johnson, PJ Kudenchuk… - Circulation, 1993 - Am Heart Assoc
BACKGROUND Implantable transvenous cardioverter-defibrillators offer a significant
opportunity to decrease procedural morbidity and medical costs in the care of patients with …
opportunity to decrease procedural morbidity and medical costs in the care of patients with …
Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients
A Schaumann, F Mühlen, B Herse, BD Gonska… - Circulation, 1998 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …
Long-acting preparations of exenatide
Exenatide has been widely used for the treatment of type 2 diabetes mellitus. However, its
short plasma half-life of 2.4 hours has limited its clinical application. The exenatide products …
short plasma half-life of 2.4 hours has limited its clinical application. The exenatide products …
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator
GH Bardy, R Yee, W Jung… - Journal of the American …, 1996 - Elsevier
OBJECTIVES.: The purpose of this study was to prospectively examine in a multicenter study
the methods of use, efficacy and complications of a unipolar cardioverter-defibrillator in …
the methods of use, efficacy and complications of a unipolar cardioverter-defibrillator in …
Limitations and late complications of third-generation automatic cardioverter-defibrillators
SO Nunain, M Roelke, T Trouton, S Osswald, YH Kim… - Circulation, 1995 - Am Heart Assoc
Background This study examines the limitations and complex management problems
associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs) …
associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs) …